Testing effectiveness (Phase 2)UnknownNCT02530411What this trial is testingFulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast CancerWho this might be right forNeoplasms Velindre NHS Trust 160
Not applicableLooking for participantsNCT07646171What this trial is testingEVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)Who this might be right forHormone Receptor Positive Breast Cancer Tel-Aviv Sourasky Medical Center 19
Not applicableUnknownNCT03979339What this trial is testingFeasibility of a New Technology for Isolating Circulating Tumour CellsWho this might be right forHER2-positive Metastatic Breast CancerOvarian CancerHormone-resistant Prostate Cancer+1 more Centre Oscar Lambret 76
Early research (Phase 1)Ended earlyNCT03861403What this trial is testingA Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid TumorsWho this might be right forSolid TumorsAdvanced Triple Negative Breast CancerAdvanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer+2 more Leap Therapeutics, Inc. 10
Not applicableStudy completedNCT05690295What this trial is testingResistance-type Exercise Training in Postmenopausal Women Survivors of Breast CancerWho this might be right forBreast Cancer SurvivorsPostmenopauseResistance Training Universidad de La Frontera 26
Testing effectiveness (Phase 2)Study completedNCT01797120What this trial is testingStudy of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AIWho this might be right forMetastatic Breast Cancer PrECOG, LLC. 131
Testing effectiveness (Phase 2)Ended earlyNCT02395627What this trial is testingReversing Therapy Resistance With Epigenetic-Immune ModificationWho this might be right forBreast Neoplasms University of California, San Francisco 38
Testing effectiveness (Phase 2)Ended earlyNCT03322215What this trial is testingHR+/HER2- Advanced Breast Cancer and Endocrine ResistanceWho this might be right forBreast Cancer Metastatic Theodoros Foukakis 42
Early research (Phase 1)WithdrawnNCT00937417What this trial is testingS0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid TumorsWho this might be right forBreast CancerHead and Neck CancerLung Cancer+2 more SWOG Cancer Research Network
Testing effectiveness (Phase 2)Temporarily pausedNCT00738777What this trial is testingPre-operative Hormonal Treatment for Hormone Receptor Positive Breast CancerWho this might be right forBreast Cancer The Netherlands Cancer Institute 250
Not applicableLooking for participantsNCT06633380What this trial is testingAlternative Physical Activity Strategies for Breast Cancer SurvivorsWho this might be right forBreast CancerInsulin ResistanceCardiometabolic Risk Factors University of Toronto 24
Testing effectiveness (Phase 2)Study completedNCT00428896What this trial is testingA Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast CancerWho this might be right forBreast Cancer University Hospital of Crete 24
Testing effectiveness (Phase 2)UnknownNCT03044730What this trial is testingPembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by SurgeryWho this might be right forEstrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+7 more Northwestern University 30
Not applicableActive Not RecruitingNCT01802346What this trial is testingControlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate CancerWho this might be right forBreast CancerHormone-resistant Prostate CancerRecurrent Prostate Cancer University of Southern California 130
Not applicableStudy completedNCT06307457What this trial is testingHR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.Who this might be right forBreast Cancer Pfizer 604
Testing effectiveness (Phase 2)Study completedNCT01831076What this trial is testingPreoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 TumorsWho this might be right forBreast CancerStage II Breast CancerStage III Breast Cancer University of Colorado, Denver 36
Early research (Phase 1)Study completedNCT01971515What this trial is testingFirst-in-Human Dose Escalation Trial in Subjects With Advanced MalignanciesWho this might be right forSolid Tumor EMD Serono 101
Early research (Phase 1)Study completedNCT04134884What this trial is testingStudy of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast CancerWho this might be right forMetastatic Breast CancerTriple Negative Breast CancerHormone Receptor Positive Tumor Kathy Miller 34
Early research (Phase 1)Active Not RecruitingNCT03939897What this trial is testingTesting the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic HER2-Negative Breast Carcinoma+2 more National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT02152943What this trial is testingEverolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive PatientsWho this might be right forAdvanced Malignant Solid NeoplasmEstrogen Receptor PositiveHER2/Neu Positive+10 more M.D. Anderson Cancer Center 37